Review Article, J Womens Health Issues Care Vol: 3 Issue: 4
Pharmacological Characteristics of Lacobacillus gasseri OLL2809 and its Application to the Endometriosis Therapy
| Masayuki Uchida*, Toshihiro Sashihara, Orie Kobayashi and Hiroyuki Itoh | |
| Food Science Research Laboratories, Division of Research and Development, Kanagawa, Japan | |
| Corresponding author : Masayuki Uchida, Ph.D. Food Science Research Laboratories, Division of Research and Development, Meiji Co. Ltd., 540 Naruda, Odawara, Kanagawa, 250-0862 Japan Tel: +81-465-37-3664; Fax: +81-465-36-2776 E mail: masayuki.uchida@meiji.com |
|
| Received: February 28, 2014 Accepted: July 31, 2014 Published: August 05, 2014 | |
| Citation: Uchida M, Sashihara T, Kobayashi O, Itoh H (2014) Pharmacological Characteristics of Lacobacillus gasseri OLL2809 and its Application to the Endometriosis Therapy. J Womens Health, Issues Care 3:4. doi:/10.4172/2325-9795.1000155 |
Abstract
Pharmacological Characteristics of Lacobacillus gasseri OLL2809 and its Application to the Endometriosis Therapy
Many probiotics have been developed for the treatment of diseases. However, there is no probiotics for the treatment of endometriosis. In the pathology of endometriosis involvement of impaired peritoneal immunosurveillance systems has been well established, suggesting the impaired activity of natural killer (NK) cell in the peritoneal cavity.
